# 18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment

> **NCT04842071** · PHASE3 · UNKNOWN · sponsor: **Centre de recherche du Centre hospitalier universitaire de Sherbrooke** · enrollment: 2500 (estimated)

## Conditions studied

- Bone Cancer
- Articular Disease
- Infectious Disease

## Interventions

- **DIAGNOSTIC_TEST:** 18F-sodium fluoride

## Key facts

- **NCT ID:** NCT04842071
- **Lead sponsor:** Centre de recherche du Centre hospitalier universitaire de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04842071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04842071, "18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04842071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*